Analysis of inhibitor binding in influenza virus neuraminidase

被引:90
|
作者
Smith, BJ
Colman, PM
Von Itzstein, M
Danylec, B
Varghese, JN
机构
[1] Biomol Res Inst, Parkville, Vic 3052, Australia
[2] Monash Univ, Dept Med Chem, Parkville, Vic 3052, Australia
关键词
influenza virus; neuraminidase inhibitors; electrostatics; X-ray crystal structures; binding energies; molecular modeling;
D O I
10.1110/ps.41801
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
2,3-didehydro-2-deoxy-N-acetylneuraminic acid (DANA) is a transition state analog inhibitor of influenza virus neuraminidase (NA). Replacement of the hydroxyl at the C-9 position in DANA and 4-amino-DANA with an amine group, with the intention of taking advantage of an increased electrostatic interaction with a conserved acidic group in the active site to improve inhibitor binding, significantly reduces the inhibitor activity of both compounds. The three-dimensional X-ray structure of the complexes of these ligands and NA was obtained to 1.4 Angstrom resolution and showed that both ligands bind isosterically to DANA. Analysis of the geometry of the ammonium at the C-4 position indicates that Glu119 may be neutral when these ligands bind. A computational analysis of the binding energies indicates that the substitution is successful in increasing the energy of interaction; however, the gains that are made are not sufficient to overcome the energy that is required to desolvate that part of the ligand that comes in contact with the protein.
引用
下载
收藏
页码:689 / 696
页数:8
相关论文
共 50 条
  • [21] Influenza virus neuraminidase inhibitors
    Gubareva, LV
    Kaiser, L
    Hayden, FG
    LANCET, 2000, 355 (9206): : 827 - 835
  • [22] Neuraminidase inhibitor resistance of the isolated influenza virus: Analysis of 54-month data from Thailand
    Yasri, Sora
    Wiwanitkit, Viroj
    ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2015, 8 (03) : 71 - U45
  • [23] Anti-Viral Inhibitor Binding to Influenza Neuraminidase by MALDI Mass Spectrometry
    Swaminathan, Kavya
    Downard, Kevin M.
    ANALYTICAL CHEMISTRY, 2012, 84 (08) : 3725 - 3730
  • [24] Neuraminidase inhibitor resistance of the isolated influenza virus: Analysis of 54-month data from Thailand
    Yasri, Sora
    Wiwanitkit, Viroj
    ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2014, 7 (06) : 268 - +
  • [25] Detection of an Influenza B Virus Strain with Reduced Susceptibility to Neuraminidase Inhibitor Drugs
    Bastien, Nathalie
    Gubbay, Jonathan B.
    Richardson, David
    Sleeman, Katrina
    Gubareva, Larisa
    Li, Yan
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (11) : 4020 - 4021
  • [26] Influenza Virus Inactivation for Studies of Antigenicity and Phenotypic Neuraminidase Inhibitor Resistance Profiling
    Jonges, Marcel
    Liu, Wai Ming
    van der Vries, Erhard
    Jacobi, Ronald
    Pronk, Inge
    Boog, Claire
    Koopmans, Marion
    Meijer, Adam
    Soethout, Ernst
    JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (03) : 928 - 940
  • [27] INFLUENZA-B VIRUS NEURAMINIDASE CAN SYNTHESIZE ITS OWN INHIBITOR
    BURMEISTER, WP
    HENRISSAT, B
    BOSSO, C
    CUSACK, S
    RUIGROK, RWH
    STRUCTURE, 1993, 1 (01) : 19 - 26
  • [28] Neuraminidase inhibitor resistance in influenza viruses
    Reece, Phillip Andrew
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (10) : 1577 - 1586
  • [29] Punicalagin is a neuraminidase inhibitor of influenza viruses
    Li, Ping
    Du, Ruikun
    Chen, Zinuo
    Wang, Yanyan
    Zhan, Peng
    Liu, Xinyong
    Kang, Dongwei
    Chen, Zhaoyu
    Zhao, Xiujuan
    Wang, Lin
    Rong, Lijun
    Cui, Qinghua
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (06) : 3465 - 3472
  • [30] Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections
    Monto, AS
    Fleming, DM
    Henry, D
    de Groot, R
    Makela, H
    Klein, T
    Elliott, M
    Keene, ON
    Man, CY
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02): : 254 - 261